Denmark Antihypertensive Industry Outlook 2022 - 2026

See how Denmark Antihypertensive performed compared to key markets such as Germany, Italy and Spain.

Key Market Indicators

Sales of antihypertensive medicine in Dane are expected to reach almost $9.4 million by 2026. Already this year, sales are estimated to be $8.8 million, up 1.3% from last year. Since 2002, the demand for antihypertensive medication has been growing at an average of 3% year-on-year. In 2021, Dane was ranked 18th in the world, with Finland overtaking it at 8.8 million. Italy, Spain, and Australia were the top three countries respectively.

Denmark Antihypertensive Market Data and Forecasts

How much will Denmark Antihypertensive Market grow to 2026?

Forecast: Renin-Angiotensin System Medicine Sales in Denmark
Forecast: Antihypertensive Medicine Sales in Denmark
Forecast: Antihypertensive Medicine Sales in Denmark
Forecast: Renin-Angiotensin System Medicine Sales in Denmark
Forecast: Antihypertensive Medicine Sales in Denmark